With a robust background in the life sciences sector, the fund manager has executed over 30 strategic investments across Europe and North America. Their focus spans early-stage ventures to growth equity, emphasizing a data-driven approach to identify high-potential opportunities. Noteworthy exits include several successful public listings and acquisitions, underscoring a strong track record in generating returns. Their investment strategy is characterized by an operator-first mentality, fostering deep partnerships with portfolio companies to drive innovation and value creation.